Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Why Options Traders Are Loading Up on Pure Storage

Institutional investors are aggressively buying Pure Storage call options as the company secures hyperscaler deals for its energy-efficient AI technology.

New Horizon Aircraft: A Speculative Microcap With Take-Off Potential

New Horizon Aircraft: A Speculative Microcap With Take-Off Potential

New Horizon Aircraft is on track to disrupt multi-billion dollar regional air markets with its Cavorite X7 hybrid eVTOL aircraft.

The 5 Best GPU-as-a-Service Providers for 2026—And 1 Clear Winner

The 5 Best GPU-as-a-Service Providers for 2026—And 1 Clear Winner

This is a look at the five pure-play GPU-as-a-service businesses, focusing on the leading play for 2026 and its upside potential.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Alphabet Tops $4 Trillion Valuation as AI Momentum Runs Hot

Alphabet (GOOGL) just topped a $4 trillion valuation for the first time in its history, becoming the world's second most valuable company.

TSMC's Strong Guidance Supports the Stock's Hot Start to 2026

TSMC shares are continuing their ascent in 2026. The company's Jan. 15 earnings release revealed solid beats and guidance that strongly surpassed expectations.

Red Cat Revenue Surges 1,800% After Crossing Into Mass Production

Red Cat Holdings has officially transitioned to mass production with record financial results fueled by the Army's adoption of its Black Widow drone system.

The 2026 Survival Kit: Gold, Defense, and Trash

A portfolio built on physical gold, national defense, and waste management offers a strategic path to capital appreciation and reliable dividend income.

inkl

Read news from The Economist, FT, and more,
with one subscription

Bank Stocks Get Punished After Earnings—Is Valuation the Real Problem?

Bank Stocks Get Punished After Earnings—Is Valuation the Real Problem?

Bank stocks fell after earnings as valuations and policy concerns weighed on the sector; Bank of America and Wells Fargo offer different risk-reward profiles.

Oklo’s Meta Deal De-Risks the Story—Rebound Setup Emerging

Oklo’s Meta Deal De-Risks the Story—Rebound Setup Emerging

Oklo is on track for a robust rebound as institutions accumulate, analysts lift targets, and short-sellers cover their positions.

CrowdStrike: A Major Bear Throws in the Towel—Upside Ahead

CrowdStrike: A Major Bear Throws in the Towel—Upside Ahead

CrowdStrike’s pullback looks like it's run out of steam, and with momentum improving and analyst support strengthening, the upside potential is real.

Tesla’s Earnings Loom With Almost No Room for Error

Tesla’s Earnings Loom With Almost No Room for Error

Tesla heads into earnings with its uptrend intact but sentiment split. The bulls are betting on long-term potential while the bears are urging caution.

Meta Compute: Inside Zuckerberg’s Massive Data Center Bet

Meta Compute: Inside Zuckerberg’s Massive Data Center Bet

Zuckerberg just announced Meta Compute, the company's initiative to greatly expand its AI infrastructure capacity. See the potential benefits and drawbacks.

This Under-the-Radar AI Stock Is Poised for 50% Upside

This Under-the-Radar AI Stock Is Poised for 50% Upside

After shares lost 28% last year, ServiceNow is poised to recover on the back of a 98% customer retention rate and 30 consecutive quarterly earnings beats.

L3Harris Blasts Off With a $1 Billion Pentagon Payload

L3Harris Blasts Off With a $1 Billion Pentagon Payload

A government investment in defense manufacturing capabilities has pushed L3Harris stock near all-time highs as the company restructures for growth.

Get all your
news in one place.

100’s of premium titles.
One news app.

5 Hot Small Caps Setting Up for Big Gains: Buy, Sell, or Hold?

Small caps are poised to lead in 2026, and these stocks are among the hottest. The question to be answered is where their stock price are heading in H1 2026.

Albemarle Sits at the Center of Lithium’s Next Cycle

Albemarle stock surged in 2025, but analysts see further upside. Rising lithium prices, storage demand, and disciplined supply could shape ALB in 2026

Qualcomm: Wall Street’s Patience Is Wearing Thin

Qualcomm’s first downgrade of 2026 has investors wondering whether this latest pullback is a warning or a buying opportunity.

Modi Momentum: Finding Stability in India’s Goldilocks Economy

India is entering a rare economic phase where high growth and low inflation are fueling a powerful rally in financial stocks and broader equities.

Get all your
news in one place.

100’s of premium titles.
One news app.

Micron: Accelerating HBM Ramp Extends Growth Into 2027

Micron is well-positioned for the HBM demand boom and is ramping production to meet unprecedented AI-driven demand for memory.

Samsara Is Forming a Triple Bottom—Time to Buy?

Oversold signals, bullish analyst targets, and a strong track record of bouncing off this level all make for an attractive risk-reward setup for Samsara.

Regional Banking Sector Near a Critical Inflection Point

Regional banks are nearing a major level, with the KRE ETF consolidating just below resistance at $70, setting up a potential breakout or double top scenario.

Broadcom Earns ‘Top Pick’ Status From Wall Street’s Biggest Banks

Analysts at big banks are bullish on Broadcom in 2026. At least three have named the stock a "top pick" for the new year.

Costco Finally Breaks Out: Is There Still Time to Buy?

COST shares are finally breaking out after a sluggish 2025, gaining 10% in just two weeks to start the year. Is there still time to buy?

Delta Hit Turbulence in Q4—Now Comes the Opportunity

Delta Air Lines reported strengths and plans to update its fleet in 2026. Analysts expressed concerns but quickly moved on, favoring the impact on growth.

A Fresh IPO That Long-Term Investors Shouldn’t Ignore

Aktis Oncology, which recently had its IPO, has gained substantial backing from Big Pharma mainstay Eli Lilly. Investors should take note of the biotech firm.

People

162,559 stories

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

333,278 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play